Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C19 | P33261 | 4/20 | 0.40 |
| ▸ | GRM4 | Q14833 | 6/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.36 |
| ▸ | GRM2 | Q14416 | 2/20 | 0.36 |
| ▸ | GRM3 | Q14832 | 2/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.36 |
| ▸ | GRM8 | O00222 | 2/20 | 0.36 |
| ▸ | GRM6 | O15303 | 2/20 | 0.36 |
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
| ▸ | GRM5 | P41594 | 1/20 | 0.36 |
| ▸ | MTOR | P42345 | 1/20 | 0.36 |
| ▸ | GRM1 | Q13255 | 1/20 | 0.36 |
| ▸ | PLCB1 | Q9NQ66 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | HSD11B1 | P28845 | 2/20 | 0.34 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.33 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.33 |
| ▸ | CES2 | O00748 | 1/20 | 0.33 |
| ▸ | CES1 | P23141 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL628239 | 0.98 | CYP2C19 (0.39) | CYP2C19GRM4CYP1A2GRM2GRM3 | |
| SCHEMBL11263069 | 0.98 | CYP2C19 (0.43) | CYP2C19GRM4CYP1A2GRM2GRM3 | |
| SCHEMBL27615428 | 0.98 | CYP2C19 (0.39) | CYP2C19GRM4CYP1A2GRM2GRM3 | |
| Hydrochloric Acid SCHEMBL28459632 | 0.98 | CYP2C19 (0.39) | CYP2C19GRM4CYP1A2GRM2GRM3 | |
| Cyclohexane SCHEMBL28031962 | 0.98 | CYP2C19 (0.43) | CYP2C19GRM4CYP1A2GRM2GRM3 | |
| Hydrochloric Acid SCHEMBL2494923 | 0.98 | CYP2C19 (0.39) | CYP2C19GRM4CYP1A2GRM2GRM3 | |
| SCHEMBL988351 | 0.93 | GRM4 (0.38) | CYP2C19GRM4CYP1A2GRM2GRM3 | |
| SCHEMBL29996840 | 0.91 | CYP2C19 (0.38) | CYP2C19GRM4CYP1A2GRM2GRM3 | |
| Hydrochloric Acid SCHEMBL25405452 | 0.91 | GRM4 (0.36) | CYP2C19GRM4CYP1A2GRM2GRM3 | |
| Hydrochloric Acid SCHEMBL3267782 | 0.91 | GRM4 (0.36) | CYP2C19GRM4CYP1A2GRM2GRM3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1509 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260138879-A1 | MODIFIED LAYERED DOUBLE HYDROXIDE (LDH), PARTICLES COMPRISING SAID LDH, AND METHOD FOR PRODUCING SAID LDH | KISUMA CHEMICALS B V (NL) | 2026-05-21 | — | — | US | claimed |
| EP-4219440-B1 | BATCH PREPARATION METHOD FOR ESTER-BASED MATERIAL | LG CHEMICAL LTD (KR) | 2026-05-06 | — | — | EP | claimed |
| US-12577191-B2 | Batch preparation method of ester-based material | LG CHEM, LTD. (KR) | 2026-03-17 | — | — | US | claimed |
| EP-3825278-B1 | METHOD FOR PREPARING HIGH-PURITY BISFLUOROSULFONYLIMIDE SALT | SHANGHAI ROLECHEM CO LTD (CN) | 2025-12-17 | — | — | EP | claimed |
| EP-4605346-A1 | MODIFIED LAYERED DOUBLE HYDROXIDE (LDH), PARTICLES COMPRISING SAID LDH, AND METHOD FOR PRODUCING SAID LDH | Kisuma Chemicals B.V. (NL) | 2025-08-27 | — | — | EP | claimed |
| EP-4219442-B1 | METHOD FOR PRODUCING ESTER-BASED COMPOSITION | LG CHEMICAL LTD (KR) | 2025-06-04 | — | — | EP | claimed |
| CN-119589305-A | Preparation method of automobile identification tag | 东莞市志兴电子五金有限公司 | 2025-03-11 | — | — | CN | claimed |
| EP-3854776-B1 | METHOD AND SYSTEM FOR PREPARATION OF ESTER-BASED COMPOSITION | LG CHEMICAL LTD (KR) | 2024-09-18 | — | — | EP | claimed |
| CN-113227064-B | Method for producing crystals of cyclohexanetricarboxylic anhydride and crystals | 三菱瓦斯化学株式会社 | 2024-07-19 | — | — | CN | claimed |
| CN-113166026-B | Preparation method and preparation system of ester composition | 株式会社LG化学 | 2024-05-14 | — | — | CN | claimed |
| US-6638494-B1 | Iron hydroxide, ferric hydrate, iron oxide, iron mixed oxide or iron; di- or polycarboxylic acid stabilizer; aggregation prevention; antitumor and contrast agents; immune boosters, magnetic resonance imaging, cell fusion, gene transfer | PILGRIMM HERBERT (DE) | 2003-10-28 | — | — | US | claimed |
| WO-2003029339-A1 | PLASTICISED POLYVINYL CHLORIDE | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2003-04-10 | — | — | WO | claimed |
| US-6303050-B1 | COMPOUNDS OF A DEFINED STRUCTURE CAN BE USED IN A PLANNED MANNER FOR BUILDING UP LIQUID-CRYSTALLINE POLYMERS AND THUS FOR CONTROLLING THE CHARACTERISTICS OF THESE POLYMERS. | DAIMLERCHRYSLER AG (DE) | 2001-10-16 | — | — | US | claimed |
| EP-0869112-A1 | Compounds, method for preparing them and preparation of liquid crystal polymers by using these compounds | Daimler-Benz Aktiengesellschaft (DE) | 1998-10-07 | — | — | EP | claimed |
| US-5616249-A | USING ALL ALIPHATIC POLYAMIDES FROM POLYAMINO COMPOUNDS AND COMPOUNDS HAVING TWO OR MORE ACID HALIDE GROUPS | IONICS, INCORPORATED (US) | 1997-04-01 | — | — | US | claimed |
| US-5276127-A | Crosslinked polyester from polyfunctional acids and alcohols | MITSUBISHI RAYON COMPANY LTD. (JP) | 1994-01-04 | — | — | US | claimed |
| US-5145987-A | Stereoselective carboyxlation | THE DOW CHEMICAL COMPANY (US) | 1992-09-08 | — | — | US | claimed |
| EP-0471302-A2 | Polyester resin for toner | MITSUBISHI RAYON CO., LTD (JP) | 1992-02-19 | — | — | EP | claimed |
| US-4622382-A | STELLATE MOLECULAR STRUCTURE, LACQUERS, BINDERS | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 1986-11-11 | — | — | US | claimed |
| US-4017429-A | CATALYTIC ESTERIFICATION WITH AN OXIRANE COMPOUND, CHROMIUM CARBOXYLATE CATALYST | AEROJET-GENERAL CORPORATION (US) | 1977-04-12 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12577191-B2 | Batch preparation method of ester-based material | PHGDH, MCCC2, PCCA | CYP2C19 238/4885GRM4 3024/4885CYP1A2 331/4885 |
| US-20260138879-A1 | MODIFIED LAYERED DOUBLE HYDROXIDE (LDH), PARTICLES COMPRISING SAID LDH, AND METHOD FOR PRODUCING SAID LDH | LDHA, LDHB, ME2 | CYP2C19 2645/4885GRM4 3596/4885CYP1A2 2192/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.